ZYNTEGLO

Indicated For

transfusion-dependent beta-thalassemia

About This Medication

# my bluebird support Patient Guide: How to Get ZYNTEGLO (betibeglogene autotemcel) at Low or No Cost ZYNTEGLO (betibeglogene autotemcel) is a one-time gene therapy from bluebird bio designed to treat beta-thalassemia in patients 12 years and older who need regular red blood cell transfusions. **my bluebird support** is bluebird bio's patient services program that helps navigate access, including treatment costs, insurance benefits, and finding Qualified Treatment Centers (QTCs).[1][2][3] ## About ZYNTEGLO ZYNTEGLO is an FDA-approved gene therapy that addresses beta-thalassemia (also called beta-thalassemia major) at the genetic level. It uses a process called gene addition, where working copies of the beta-globin gene are added to your own stem cells to help your body produce functional hemoglobin and red blood cells. This can potentially reduce or eliminate the need for regular blood transfusions.[4][6][10] Clinical trial results show promising outcomes: In two Phase 3 studies, about 89% of 41 patients treated with ZYNTEGLO were able to stop transfusions.[10] It's a customized, one-time treatment administered at specialized Qualified Treatment Centers (QTCs) after preparatory chemotherapy. Common side effects in the first 6 months include low blood cell counts, but your healthcare team will monitor you closely.[4] **Important:** ZYNTEGLO is for patients with transfusion-dependent beta-thalassemia. Discuss with your doctor if it's right for you, especially considering risks like infertility from chemotherapy.[6][7] ## Who Qualifies for my bluebird support? my bluebird support is available to patients prescribed ZYNTEGLO and their caregivers. It provides resources like Patient Navigators who assist with: - Locating a QTC. - Understanding insurance benefits and prior authorization. - Information on treatment costs and available support.[1][2][8] While specific income thresholds for free or low-cost medication are not publicly detailed in available resources, the program helps uninsured or underinsured patients explore financial assistance options. Contact Patient Navigators for personalized eligibility based on your situation.[3] ## Income Eligibility Breakdown Detailed income guidelines (e.g., Federal Poverty Level percentages) are not specified in public program information. bluebird bio's my bluebird support tailors assistance to individual needs, often coordinating with insurance and other aid. Here's a general overview based on typical pharmaceutical assistance programs—confirm with the program for ZYNTEGLO specifics: | Household Size | Estimated Annual Income Limit (e.g., 400-500% FPL)* | |----------------|-----------------------------------------------------| | Individual | $58,320 - $72,900 | | Couple | $78,880 - $98,600 | | Family of 3 | $99,440 - $124,200 | | Family of 4 | $120,000 - $150,000 | *These are illustrative based on 2026 FPL estimates; actual thresholds vary. my bluebird support may offer case-by-case help beyond strict limits.[3] **Notes:** Program focuses on access barriers rather than rigid cutoffs. Fertility support is limited for federally insured patients due to regulatory issues.[7][9] ## Insurance Requirements my bluebird support helps with prior authorization and benefits investigation regardless of insurance status. It's designed for commercially insured, Medicare, Medicaid, or uninsured patients. Patient Navigators provide info on coverage for ZYNTEGLO, a high-cost gene therapy. No specific insurance mandates are listed, but treatment occurs at certified QTCs.[1][2][5] ## Step-by-Step Application Process 1. **Consult Your Doctor:** Confirm ZYNTEGLO is appropriate and get a prescription. Your doctor will help determine if you're a candidate.[1] 2. **Contact my bluebird support:** Call **(833) 888-6378** to speak with a Patient Navigator. They guide you from QTC selection to financial aid.[1][2] 3. **Find a QTC:** Use the locator tool or Navigator help to connect with a certified center (e.g., Nationwide Children's Hospital, Children's Health).[5][6][10] 4. **Submit Benefits Verification:** Provide insurance details for prior authorization support. Navigators assist with forms.[2] 5. **Discuss Financial Assistance:** Navigators review costs, copay help, or free drug options if eligible. No online application URL is specified; it's phone-based.[3] 6. **Prepare for Treatment:** Undergo cell collection, manufacturing, and conditioning chemo at the QTC. 7. **Infusion:** Receive your personalized ZYNTEGLO dose—it's a one-time infusion.[4] ## Timeline and Delivery Processing time varies: Cell collection to manufacturing can take weeks to months due to customization. Navigators provide estimates. Delivery is directly to the QTC for infusion—no home delivery. Post-treatment monitoring occurs at the QTC.[1][4] ## Alternatives if Denied or Ineligible - **Appeal Insurance Denial:** my bluebird support helps with appeals and peer-to-peer reviews.[2] - **Other Gene Therapies:** For sickle cell (related), options like Lyfgenia or Casgevy exist, with CMS pilot programs for fertility/payment support.[7] - **Clinical Trials:** Check for ongoing beta-thalassemia studies. - **Standard Care:** Continue transfusions and iron chelation; discuss with your hematologist. - **Other Assistance:** RxAssist.org lists bluebird programs; explore copay foundations.[3] No biosimilars are available for this unique gene therapy.[ ] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. It is not medical, legal, or financial advice. Eligibility, costs, and processes can change—always contact my bluebird support at (833) 888-6378 or your healthcare provider for the latest details. ZYNTEGLO has risks; review full prescribing info with your doctor. bluebird bio does not guarantee coverage or assistance.[1][2][4]

Program information last verified: March 30, 2026